- Home
- VERA vs HURN Comparison
VERA vs HURN Comparison
Compare VERA & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- HURN
- Stock Information
- Founded
- VERA 2016
- HURN 2002
- Country
- VERA United States
- HURN United States
- Employees
- VERA N/A
- HURN N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- HURN Professional Services
- Sector
- VERA Health Care
- HURN Consumer Discretionary
- Exchange
- VERA Nasdaq
- HURN Nasdaq
- Market Cap
- VERA 2.5B
- HURN N/A
- IPO Year
- VERA 2021
- HURN 2004
- Fundamental
- Price
- VERA $42.01
- HURN $117.22
- Analyst Decision
- VERA Strong Buy
- HURN Strong Buy
- Analyst Count
- VERA 9
- HURN 4
- Target Price
- VERA $53.56
- HURN $131.75
- AVG Volume (30 Days)
- VERA 683.6K
- HURN 66.1K
- Earning Date
- VERA 11-07-2024
- HURN 10-29-2024
- Dividend Yield
- VERA N/A
- HURN N/A
- EPS Growth
- VERA N/A
- HURN 14.29
- EPS
- VERA N/A
- HURN 4.16
- Revenue
- VERA N/A
- HURN $1,425,021,000.00
- Revenue This Year
- VERA N/A
- HURN $11.16
- Revenue Next Year
- VERA N/A
- HURN $8.65
- P/E Ratio
- VERA N/A
- HURN $25.27
- Revenue Growth
- VERA N/A
- HURN 12.76
- 52 Week Low
- VERA $9.68
- HURN $84.26
- 52 Week High
- VERA $50.78
- HURN $115.65
- Technical
- Relative Strength Index (RSI)
- VERA 52.57
- HURN 66.87
- Support Level
- VERA $39.22
- HURN $103.24
- Resistance Level
- VERA $50.00
- HURN $108.75
- Average True Range (ATR)
- VERA 2.41
- HURN 2.06
- MACD
- VERA 0.24
- HURN 0.22
- Stochastic Oscillator
- VERA 28.53
- HURN 100.00
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.